Risk factors in retinopathy of the premature;Factores de riesgo en la retinopatia del prematuro

Anales Espanoles de Pediatria

Volumn 47, Issue 2, 1997, Pages 172-176

  Olea Vallejo, J L ^a   Corretger Ruhi, F J ^a   Salvat Serra, M ^a   Frau Rotger, E ^a   Galiana Ferre, C ^a   Fiol Jaume, M ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Low birth weight; Oxygen inhalation therapy; Retinopathy of the premature; Risk factors

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; OXYGEN THERAPY; PREMATURITY; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; RISK FACTOR;

FEMALE; HUMANS; INFANT, NEWBORN; MALE; OXYGEN INHALATION THERAPY; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037478125     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Valentine PH, Jackson JC, Kalina RE, Woodrum DE: Increased survival of low birth weight infants: impact on the incidence of retinopathy of prematurity. Pediatrics 1989; 84:442-445.
2. The Committee for the classification of retinopathy or prematurity: An international classification for retinopathy of prematurity. Arch Ophthalmol 1984; 102:1130-1134.
3. Cryotherapy for retinopathy of prematurity cooperative group: Multi-center trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988; 106:471-479.
4. Cryotherapy for retinopathy of prematurity cooperative group: Multi-center trial of cryotherapy for retinopathy of prematurity: three-month outcome. Arch Ophthalmol 1990; 108:195-204.
5. Cryotherapy for retinopathy of prematurity cooperative group: The natural ocular outcome of premature birth and retinopathy: status at 1 year. Arch Ophthalmol 1994; 112:903-912.
6. Cryotherapy for retinopathy of prematurity cooperative group: Multi-center trial of cryotherapy for retinopathy of prematurity. 3 1/2-year outcome structure and function. Arch Ophthalmol 1993; 111:339-344.
7. Flynn JT. Retinopathy of prematurity. In: Eichenbaum JW, Mamelok A, Mittl RN, Orellana J eds. Treatment of retinopathy of prematurity. Chicago/London/Boca raton/Littleton, Mass: Year Book Medical Publishers, Inc., 1990; págs. 81-109.
8. Cryotherapy for retinopathy of prematurity cooperative group: Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology 1993; 100:230-237.
9. Finer NN, Schindler RF, Peters KL: Vitamin E and retrolental fibroplasia: Improve visual outcome with early vitamin E. Ophthalmology 1983; 90:428-435.
10. Hittner HM, Godio LB, Rudolph AJ: Retrolental fibroplasia: Efficacy of vitamin E in double-blind clinical study of preterm infants. N Engl J Med 1981; 305:1365-1370.
11. Shahinian L, Malachowski N: Retrolental fibroplasia: A new analysis of risk factors based on recent cases. Arch Ophthalmol 1978; 96:70-74.
12. Kinsey VE, Zacharias L: Retrolental fibroplasia: Incidence in different localities in recent years and a correlation of the incidence with treatment. JAMA 1949; 139:572-578.
13. Kinsey VE, Hemphill FM: Etiology of retrolental fibroplasia and preliminary report of cooperative study of retrolental fibroplasia. Trans Am Acad Ophthalmol 1955; 59:15-24.
14. Pallás Alonso CR, Tejadas Palacios P, Medina López MC, Martin Puerto MJ, Orbea Gallardo C, Barrio Andrés MC: Retinopatía del premature: nuestra experiencia. An Esp Pediatr 1995; 42:52-56.
15. Keith CG, Doyle LW: Retinopathy of prematurity in infants weighing 1000-1499 g at birth. J Paediatr Child Health 1995; 31:134-136.
16. Cryotherapy for retinopathy of prematurity cooperative group: Incidence and early course of retinopathy of prematurity. Ophthalmology 1991; 98:1628-1640.
17. Gunn TR, Easdoun J, Arterbridge EW, Aranda JW: Risk factors in retrolental fibroplasia. Pediatrics 1980; 65:1096-1100.
18. Puklin J, Simon RM, Ehrenkranz RZ: Influenza on RLF of intramuscular vitamin E administration during respiratory distress syndrome. Ophthalmology 1982; 89:96-102.
19. Bancalari E, Flynn J,Goldberg RN: Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatrics 1987; 76:663-669.
20. Lanman JT: Retrolental fibroplasia and oxigen therapy. JAMA 1954; 155:223-226.
21. Procianoy S, Garcia Prats JA, Hittner HM, Adams JM, Rudolph AJ: An association between ROP and intraventricular hemorrhage in very low bitrh weight infants. Acta Paediatr Scand 1981; 70:473-477.
22. Hammer ME, Mullen PW, Ferguson JG, Pai S, Cosby C, Jackson KL: Logistic analysis of risk factors in acute retinopathy of prematurity. Am J Ophthalmol 1986; 102:1-6.
23. Sacks LM, Schaffer DB, Anday EK, Peckham GJ, Papadopoulos MD: Retrolental fibroplasia and blood transfusion in very low birthweight infants. Pediatrics 1981; 68:770-774.
24. Repka MX, Hudak ML, Parsa CF, Tielsch JM: Calf lung surfactant extract prophylaxis and retinopathy of prematurity. Ophthalmology 1992; 99:531-536.
25. Repka MX, Hardy RJ, Phelps DL, Summers CG: Surfactant prophylaxis and retinopathy of prematurity. Arch Ophthalmol 1993; 111:618-620.